Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Reliable volumetry of the cervical spinal cord in MS patient follow-up data with cord image analyzer (Cordial).
Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies.
Masitinib is being investigated in the treatment of amyotrophic lateral sclerosis (ALS)
Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report.
Studying both sexes: a guiding principle for biomedicine.
Interferon-β-1b: a review of its use in multiple sclerosis.
Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis.
Pervasive Axonal Transport Deficits in Multiple Sclerosis Models.
Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series.
A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
Interplay between exercise and dietary fat modulates myelinogenesis in the central nervous system.
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.
A much-needed focus on progression in multiple sclerosis.
Study of teriflunomide in reducing the frequency of relapses and accumulation of disability in patients with multiple sclerosis (TEMSO)
Teva Pharmaceutical Industries Limited's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.
Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158N murine oligodendrocytes.
Merck: Regulatory Update on Cladribine Tablets
FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway.
Association of Immunotherapies With Outcomes in Relapsing-Remitting Multiple Sclerosis.
Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
PHENYTEK®* Capsules (extended phenytoin sodium capsules, USP)
Treatment of multiple sclerosis with the pregnancy hormone estriol.
Risk of natalizumab-associated progressive multifocal leukoencephalopathy.

Pages